APA (7th ed.) Citation

Gordon, K. B., Tada, Y., Anadkat, M. J., Choon, S. E., Elewski, B., Barker, J. N., . . . Thaçi, D. (2025). Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions. Dermatology & Therapy, 15(2), 395. https://doi.org/10.1007/s13555-024-01325-7

Chicago Style (17th ed.) Citation

Gordon, Kenneth B., et al. "Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions." Dermatology & Therapy 15, no. 2 (2025): 395. https://doi.org/10.1007/s13555-024-01325-7.

MLA (9th ed.) Citation

Gordon, Kenneth B., et al. "Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological Conditions." Dermatology & Therapy, vol. 15, no. 2, 2025, p. 395, https://doi.org/10.1007/s13555-024-01325-7.